Recent News

• 05.20.2025 - IO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare Conference
• 05.14.2025 - IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights
• 04.26.2025 - IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025
• 03.25.2025 - IO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting
• 03.04.2025 - IO Biotech Reports 2024 Business Highlights

Recent Filings

• 05.14.2025 - 8-K Current report
• 05.14.2025 - EX-99.1 EX-99.1
• 05.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.30.2025 - 8-K Current report
• 04.25.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.25.2025 - DEF 14A Other definitive proxy statements
• 04.25.2025 - ARS Annual Report to Security Holders
• 04.07.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 04.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.04.2025 - 4 Statement of changes in beneficial ownership of securities